Bertault D, Benoit G, Vieillefond A, Ribaud P, Bensadoun H, Jardin A
Service d'Urologie, Hôpital de Bicêtre, Le Kremlin-Bicêtre.
Ann Urol (Paris). 1990;24(2):97-101; discussion 102.
Twenty-six patients with a PT1 urothelial bladder tumour were treated by transurethral resection and endovesical BCG. The authors compared previously untreated patients with patients with a history of bladder tumour present for an average of 4.6 years. The results of this study show that 72% of bladders in the first group were preserved compared with 53% in the second group. 45% of patients in whom the tumour invaded the superficial lamina propria developed a recurrence compared with 100% of tumours with invasion of the deep lamina propria. 25% of patients who developed a recurrence died in the course of this study.
26例PT1期膀胱尿路上皮肿瘤患者接受了经尿道切除术和膀胱内卡介苗灌注治疗。作者将未经治疗的患者与平均患有膀胱肿瘤4.6年的患者进行了比较。这项研究的结果表明，第一组中72%的膀胱得以保留，而第二组为53%。肿瘤侵犯浅固有层的患者中有45%出现复发，而侵犯深固有层的肿瘤复发率为100%。在本研究过程中，出现复发的患者中有25%死亡。
